DAIVITAMIX INJECTION Vitamin B1 B6 B12 Injection
DAIVITAMIX INJECTION 原价为:€190.40。当前价格为:€168.00。
返回产品
OTSUKA NORMAL SALINE INJECTION
OTSUKA NORMAL SALINE INJECTION (100MLx10PCS) 原价为:€78.40。当前价格为:€69.44。

Tranexamic Acid Injection 1000mg/10mL “Nisshin” 10mL x 50PCS

原价为:€190.40。当前价格为:€168.00。

Tranexamic Acid Injection 1000mg/10mL “Nisshin” is a Japanese injectable preparation containing 1000mg of tranexamic acid per 10mL ampoule. It is an antifibrinolytic agent used under healthcare professional supervision for clinical bleeding-control settings. Package: 10mL x 50PCS.

描述

Tranexamic Acid Injection 1000mg/10mL “Nisshin”

Tranexamic Acid Injection 1000mg/10mL “Nisshin”, also known as トラネキサム酸注 1000mg/10mL「日新」 or 日新傳明酸注射劑1000mg/10mL, is a Japanese tranexamic acid injectable preparation containing 1000mg of tranexamic acid in each 10mL ampoule.

Tranexamic acid is an antifibrinolytic agent used in clinical settings where control of excessive bleeding may be required. This product is intended for use by or under the supervision of qualified healthcare professionals.

Product Information

  • Product Name: Tranexamic Acid Injection 1000mg/10mL “Nisshin”
  • Japanese Name: トラネキサム酸注 1000mg/10mL「日新」
  • Chinese Name: 日新傳明酸注射劑1000mg/10mL
  • Active Ingredient: Tranexamic Acid
  • Strength: 1000mg / 10mL
  • Form: Injection ampoule
  • Package: 10mL x 50PCS
  • Total Quantity: 50 ampoules per box
  • Administration Route: Intravenous injection, intravenous drip infusion or intramuscular injection as directed by a healthcare professional
  • Manufacturer: Nisshin Pharmaceutical Co., Ltd.
  • Origin: Japan

Key Features

  • Japanese tranexamic acid injectable preparation
  • Contains 1000mg tranexamic acid per 10mL ampoule
  • Antifibrinolytic agent used in clinical bleeding-control settings
  • Suitable for professional medical use only
  • May be used by healthcare professionals during or after surgical procedures when appropriate
  • Package size: 10mL x 50PCS

About Tranexamic Acid

Tranexamic acid is an antifibrinolytic ingredient that helps inhibit the breakdown of fibrin. It is commonly used in medical settings where the management of bleeding is clinically necessary. The use of injectable tranexamic acid should always be determined by a qualified healthcare professional based on the patient’s condition.

Active Ingredient

  • Tranexamic Acid: 1000mg per 10mL ampoule

Indications and Professional Use

This product is a medical injectable preparation. Based on the provided product information, it may be used by healthcare professionals for bleeding management in appropriate clinical situations.

  • Clinical management of excessive bleeding
  • Use in surgical or post-surgical bleeding-control settings
  • Use where antifibrinolytic support is required
  • Use according to physician assessment and local medical guidelines

Important: This product should not be used for cosmetic, whitening or pigmentation-related purposes unless specifically prescribed and supervised by a qualified healthcare professional in accordance with applicable laws and medical standards.

Dosage and Administration

  • Usual Adult Dosage: 250–500mg of tranexamic acid per day, divided into 1–2 doses, administered intravenously or intramuscularly.
  • During or After Surgery: 500–1000mg may be administered intravenously, or 500–2500mg may be administered by intravenous drip infusion as necessary.
  • Dosage Adjustment: Dosage may be adjusted according to age, symptoms and clinical condition.
  • Administration: Use only under the instruction and supervision of a qualified healthcare professional.

Precautions

  • This product is an injectable medicine and should be used only by or under the supervision of qualified healthcare professionals.
  • Do not self-administer unless specifically instructed and supervised by a licensed healthcare provider.
  • Avoid use in patients with known hypersensitivity to tranexamic acid or any component of the product.
  • Use with caution in patients with renal impairment, as dosage adjustment may be necessary.
  • Assess patient risk factors for thrombosis or thromboembolic events before use.
  • Patients using anticoagulants, clotting-related medicines or medicines affecting coagulation should consult a doctor before use.
  • Use during pregnancy or breastfeeding should only occur after consultation with a healthcare professional.
  • Safety in children has not been fully established; use requires careful medical judgment.
  • Injection-site pain, redness, rash, itching or allergic reactions may occur.
  • If any abnormal symptoms or allergic reactions occur, discontinue use and seek medical attention immediately.
  • Follow the official product leaflet, label instructions and healthcare professional guidance.

Possible Side Effects

  • Injection-site pain or redness
  • Rash or itching
  • Allergic reaction
  • Gastrointestinal discomfort
  • Dizziness or headache
  • Rare risk of thromboembolic events in susceptible patients

If you notice any adverse reaction or unusual symptom, seek medical attention immediately.

Storage

  • Store in a cool, dry and dark place.
  • Keep away from direct sunlight.
  • Keep out of reach of children.
  • Keep in original packaging until use.
  • Do not use after the expiry date.

Important Notice

Tranexamic Acid Injection 1000mg/10mL “Nisshin” is a medical injectable preparation. It should only be administered by trained medical personnel or under professional medical supervision. This product is not intended for unsupervised cosmetic injection or self-administration.

Disclaimer

The information provided is for general product reference only and does not replace professional medical advice, diagnosis, treatment, official product labeling, package insert instructions or local regulatory requirements. Always consult a qualified healthcare professional before use.

其他信息
OriginJapan